Ligand validation:4U80

ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER

ANP is a Ligand Of Interest in 4U80 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4U80_ANP_A_501	82%	9%	0.109	0.965	2.85	1.6	6	4	2	0	100%	1
5YT3_ANP_A_401	93%	10%	0.086	0.983	1.81	2.45	7	6	0	0	100%	1
4U7Z_ANP_A_503	85%	9%	0.106	0.971	2.88	1.57	7	5	2	0	100%	1
4U81_ANP_A_503	83%	27%	0.109	0.969	1.39	1.54	4	5	2	0	100%	1
7M0X_ANP_A_801	82%	51%	0.132	0.989	1.02	0.87	3	2	1	0	100%	1
6PP9_ANP_A_801	76%	47%	0.149	0.985	1.07	0.97	4	2	0	0	100%	1
8PS7_ANP_A_704	100%	43%	0.023	0.994	1.15	1.05	4	2	0	0	100%	1
9AVR_ANP_A_501	100%	36%	0.034	0.991	1.05	1.46	2	5	2	0	100%	1
4BRA_ANP_A_1394	100%	12%	0.037	0.993	2.3	1.8	10	6	3	0	100%	1
4DFX_ANP_E_402	100%	32%	0.036	0.989	1.35	1.35	4	2	1	0	100%	1
3CJA_ANP_A_501	100%	13%	0.037	0.988	1.9	2.1	8	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.